Similar articles for PMID: 15299837

Year	Number of Results
1995	2
1998	1
2004	1
2005	5
2006	9
2007	8
2008	13
2009	9
2024	0

1

Benzoic acid inhibitors of influenza virus neuraminidase.

Luo M, Jedrzejas MJ, Singh S, White CL, Brouillette WJ, Air GM, Laver WG. Luo M, et al. Acta Crystallogr D Biol Crystallogr. 1995 Jul 1;51(Pt 4):504-10. doi: 10.1107/S0907444994011698. Acta Crystallogr D Biol Crystallogr. 1995. PMID: 15299837

2

A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase.

Jedrzejas MJ, Singh S, Brouillette WJ, Air GM, Luo M. Jedrzejas MJ, et al. Proteins. 1995 Oct;23(2):264-77. doi: 10.1002/prot.340230215. Proteins. 1995. PMID: 8592707

3

Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.

Zhang Q, Yang J, Liang K, Feng L, Li S, Wan J, Xu X, Yang G, Liu D, Yang S. Zhang Q, et al. J Chem Inf Model. 2008 Sep;48(9):1802-12. doi: 10.1021/ci800041k. Epub 2008 Aug 16. J Chem Inf Model. 2008. PMID: 18707092

4

On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).

Mitrasinovic PM. Mitrasinovic PM. Biophys Chem. 2009 Mar;140(1-3):35-8. doi: 10.1016/j.bpc.2008.11.004. Epub 2008 Nov 20. Biophys Chem. 2009. PMID: 19117662

5

Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.

Du QS, Wang SQ, Chou KC. Du QS, et al. Biochem Biophys Res Commun. 2007 Oct 19;362(2):525-31. doi: 10.1016/j.bbrc.2007.08.025. Epub 2007 Aug 13. Biochem Biophys Res Commun. 2007. PMID: 17707775

6

Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors.

Maring CJ, Stoll VS, Zhao C, Sun M, Krueger AC, Stewart KD, Madigan DL, Kati WM, Xu Y, Carrick RJ, Montgomery DA, Kempf-Grote A, Marsh KC, Molla A, Steffy KR, Sham HL, Laver WG, Gu YG, Kempf DJ, Kohlbrenner WE. Maring CJ, et al. J Med Chem. 2005 Jun 16;48(12):3980-90. doi: 10.1021/jm049276y. J Med Chem. 2005. PMID: 15943472

7

Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.

Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Zhang J, et al. Bioorg Med Chem. 2008 Apr 1;16(7):3839-47. doi: 10.1016/j.bmc.2008.01.036. Epub 2008 Jan 30. Bioorg Med Chem. 2008. PMID: 18304821

8

Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase.

Chand P, Kotian PL, Morris PE, Bantia S, Walsh DA, Babu YS. Chand P, et al. Bioorg Med Chem. 2005 Apr 1;13(7):2665-78. doi: 10.1016/j.bmc.2005.01.042. Bioorg Med Chem. 2005. PMID: 15755666

9

Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.

Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Zhang J, et al. Bioorg Med Chem. 2007 Apr 1;15(7):2749-58. doi: 10.1016/j.bmc.2007.01.020. Epub 2007 Jan 19. Bioorg Med Chem. 2007. PMID: 17287121

10

Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core.

Wang GT, Wang S, Gentles R, Sowin T, Maring CJ, Kempf DJ, Kati WM, Stoll V, Stewart KD, Laver G. Wang GT, et al. Bioorg Med Chem Lett. 2005 Jan 3;15(1):125-8. doi: 10.1016/j.bmcl.2004.10.022. Bioorg Med Chem Lett. 2005. PMID: 15582424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

44 results

Results by year